Application 205077
- Type
- ANDA
- Sponsor
- PII
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 5MG | No | No |
| 002 | DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 10MG | No | No |
| 003 | DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 15MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42543-500 | dextroamphetamine sulfate | dextroamphetamine sulfate | Vensun Pharmaceuticals, LLC. | ANDA | Current |
| 42543-501 | dextroamphetamine sulfate | dextroamphetamine sulfate | Vensun Pharmaceuticals, LLC. | ANDA | Current |
| 42543-502 | dextroamphetamine sulfate | dextroamphetamine sulfate | Vensun Pharmaceuticals, LLC. | ANDA | Current |